Health

Sunway Medical Centre Penang Receives Dual Honours at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition for Healthcare Excellence and Brand Leadership

SINGAPORE, Aug. 27, 2026 /PRNewswire/ -- Sunway Medical Centre Penang (SMCP) has been honoured with the Corporate Excellence and Inspirational Brand awards at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition by Enterprise Asia, recognising its strong growth trajectory as a leading ...

2026-08-27 16:27 3502

Bowtie Takes Lead in Responding to HKFI's "Best Practice on Critical Illness Definitions Standardization"

Upholding the "Meet-or-Better-Off" Principle:  Extending Upgrades to Not Only New Policies But Also Existing Customers HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Bowtie Life Insurance Company Limited ("Bowtie"), Hong Kong's first virtual insurer[1], today announced that it will fully adopt the "Bes...

2026-08-27 15:13 2036

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events to accelerate cross-border partnerships in Hong Kong.

2026-08-27 12:06 2853

Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems

TAIPEI, Aug. 27, 2026 /PRNewswire/ -- Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade solution deliver...

2026-08-27 11:00 2124

Cansurvive to hold 16th International Conference on Holistic Healing from Cancer spotlighting the link between infection and cancer

KUALA LUMPUR, Malaysia, Aug. 27, 2026 /PRNewswire/ -- Cansurvive Centre Malaysia Berhad, a non-profit cancer charity organisation, announces its 16th Malaysian International Conference on Holistic Healing from Cancer, themed "Cancer & Infection: Breaking the Cycle". The full-day conference will b...

2026-08-27 09:00 3640

Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result

SHANGHAI and LAGUNA HILLS, Calif., Aug. 26, 2026 /PRNewswire/ -- The complete results of AIntibody, the first international AI antibody design competition, have now been formally published inNature Biotechnology.

2026-08-27 08:00 2507

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's biologic...

2026-08-27 05:00 2159

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

Results Highlights for Interim Results ended 30 June 2026 Revenue reached RMB1,006.5 million, increasing by 21.0% YoY Gross profit amounted to RMB341.7 million, increasing by 0.7% YoY Gross profit margin was 34.0% HONG KONG, Aug. 26, 2026 /PRNewswire/ -- On August 26, 2026, Viva Biotech Holdings G...

2026-08-26 22:57 4646

Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey MUMBAI, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released itsSustainability Re...

2026-08-26 22:49 4800

ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease

Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority Review Voucher, subject to approval and applicable requirements BRISBANE, Calif., Aug. 26, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company adv...

2026-08-26 21:00 2679

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic cancer, glioblastoma, and other lethal malignancies NEW YORK, Aug. 26, 2026 /PRNewswire/...

2026-08-26 20:38 2502

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

SEATTLE and RICHMOND, BC, Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. (SZSE: 301047), today announced a non-exclusive licensing agreement covering Monod Bio's proprietar...

2026-08-26 20:02 1668

PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide

Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expanding access to AI-assisted colonoscopy across USA, EMEA, JAPAC and LATAM. TOKYO, Aug. 26, 2026 /PRNewswire/ -- PENTAX Medical, a HOYA Group c...

2026-08-26 20:00 2170

SU Group Wins US$2.4 Million Follow-on Award, Expanding Landmark Smart-Hospital Project to US$13.7 Million

Additional Award Broadens the Company's Role in Mission-Critical Healthcare Infrastructure and Strengthens Revenue Visibility HONG KONG, Aug. 26, 2026 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services compa...

2026-08-26 20:00 2980

From Strategy to Value: Neutech's 2026 Interim Results Confirm the Growth Logic of Its "Education-Healthcare-Wellness" Ecosystem

HONG KONG and DALIAN, China, Aug. 26, 2026 /PRNewswire/ -- On 26 August 2026, Neutech Group Limited (Stock Code: 9616.HK) released its interim results. For the first half of 2026, the Group firmly implemented its core strategy of "education-healthcare-wellness", continued to deepen business deplo...

2026-08-26 19:24 3473

Alebund Pharmaceuticals Announces 2026 Interim Results

SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period...

2026-08-26 18:59 2798

China's BCI Race Accelerates: Gestala Raises US$84 Million in Six Months

SHANGHAI and CHENGDU, China, Aug. 26, 2026 /PRNewswire/ -- Gestala officially launched on January 1, 2026. Six months later, the company had completed two financing rounds totaling RMB 570 million, or approximately US$84 million. The financing reflects growing investor interest in alternatives t...

2026-08-26 14:36 1533

Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment

* FDA IND Clearance for CBL-0201WR—Caliway has cleared its Investigational New Drug application for CBL-0201WR, a Phase 2 trial evaluating CBL-514 in combination with tirzepatide. * U.S. IRB Approval for Pivotal Phase 3 Trial SUPREME-01 (CBL-0301)—The protocol amendment for the pivotal Phase ...

2026-08-26 09:24 993

HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell

KEY POINTS * First patient safely dosed in Phase 1 KOALA trial evaluating KMCAR™ T-cell therapy in patients with relapsed/refractory kappa-restricted multiple myeloma  * Patient was monitored after initial dose to assess response and side-effects, with the treatment seen as well tolerated, an...

2026-08-26 08:00 1026

MINISH USA Highlights a Tooth-Preserving Approach Amid Growing Conversations Around Cosmetic Dentistry

MINISH USA highlights a restorative approach centered on preserving natural tooth structure. LOS ANGELES, Aug. 25, 2026 /PRNewswire/ -- Conversations around cosmetic dentistry are evolving as patients become more informed about treatment options, tooth preparation, and long-term outcomes. Recent...

2026-08-26 00:00 847
1 ... 3456789 ... 867